Albany

This research aims to observe and understand people living with chronic hepatitis B in Australia. It focuses on tracking how these individuals are linked to care and their treatment needs through a national network of diverse healthcare services. The study includes individuals diagnosed with chronic hepatitis B, whether newly or previously diagnosed, to provide a comprehensive view of this population. Participants will not receive any new treatments or interventions as part of this study. Instead, researchers will collect enrollment data such as demographics, laboratory test results, liver disease assessments, treatment history, and clinical management information from those attending participating clinics for hepatitis B care. Follow-up data on treatment, clinical management, liver disease stage, and laboratory parameters will be gathered at each visit or at least once every 12 months. Participants will be involved through regular visits to healthcare services where their health information related to hepatitis B care will be recorded and monitored over time. Researchers will assess laboratory results, disease progression, and treatment patterns to characterize the hepatitis B infection within this group. The main study outcome is to understand the characteristics of hepatitis B in this population by July 2027, with ongoing data collection during the study period.